Neuberger Berman Group LLC Cabaletta Bio, Inc. Transaction History

Neuberger Berman Group LLC

  • $130 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025
BUY
$1.39 - $2.74 $14,685 - $28,948
10,565 New
10,565 $14,000
Q1 2024

Nov 14, 2024
BUY
$16.79 - $25.38 $2.76 Million - $4.18 Million
164,605 New
164,605 $2.81 Million
Q1 2024

May 13, 2024
BUY
$16.79 - $25.38 $2.76 Million - $4.18 Million
164,605 New
164,605 $2.81 Million

Others Institutions Holding CABA

# of Institutions
91
Shares Held
80.2M
Call Options Held
406K
Put Options Held
90.9K
View Full List

About Cabaletta Bio, Inc.

CABA Quotes by TradingView
  • Ticker CABA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,014,000
  • Market Cap $71.7M
  • Description
  • Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...
More about CABA
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email